China Isotope & Radiation (HKSE:01763) Days Payable : 56.80 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Days Payable?

China Isotope & Radiation's average Accounts Payable for the six months ended in Dec. 2023 was HK$646 Mil. China Isotope & Radiation's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$2,075 Mil. Hence, China Isotope & Radiation's Days Payable for the six months ended in Dec. 2023 was 56.80.

The historical rank and industry rank for China Isotope & Radiation's Days Payable or its related term are showing as below:

HKSE:01763' s Days Payable Range Over the Past 10 Years
Min: 39.89 Med: 60.5 Max: 72.38
Current: 65.03

During the past 9 years, China Isotope & Radiation's highest Days Payable was 72.38. The lowest was 39.89. And the median was 60.50.

HKSE:01763's Days Payable is ranked worse than
54.88% of 789 companies
in the Medical Devices & Instruments industry
Industry Median: 72.55 vs HKSE:01763: 65.03

China Isotope & Radiation's Days Payable declined from Dec. 2022 (59.28) to Dec. 2023 (56.80). It may suggest that China Isotope & Radiation accelerated paying its suppliers.

China Isotope & Radiation Days Payable Historical Data

The historical data trend for China Isotope & Radiation's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Days Payable Chart

China Isotope & Radiation Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

54.60

39.89

51.77

60.50

65.48

China Isotope & Radiation Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial											45.21	71.34	59.28	76.92	56.80

Competitive Comparison of China Isotope & Radiation's Days Payable

For the Medical Devices subindustry, China Isotope & Radiation's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Isotope & Radiation's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Days Payable distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's Days Payable falls into.

China Isotope & Radiation Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

China Isotope & Radiation's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (551.771	+	685.436)	/	2 )	/	3448.415	*	365
=	618.6035					/	3448.415	*	365
=	65.48

China Isotope & Radiation's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (606.058	+	685.436)	/	2 )	/	2074.907	*	365 / 2
=	645.747					/	2074.907	*	365 / 2
=	56.80

China Isotope & Radiation Days Payable Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

China Isotope & Radiation (HKSE:01763) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089

Website

https://www.china-isotope.com

China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Ubs Group Ag	2201 Interest of corporation controlled by you
Li Hongbo	2201 Interest of corporation controlled by you
Lianwen Ltd	2101 Beneficial owner
Invesco Advisers, Inc.	2102 Investment manager
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Invesco Hong Kong Limited	2102 Investment manager
Invesco Corporate Class Inc.	2106 Person having a security interest in shares
M&g Plc	2201 Interest of corporation controlled by you
Shanghai Industrial Holdings Limited	2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited	2201 Interest of corporation controlled by you
Serenity Investment Master Fund Limited	2101 Beneficial owner
Serenity Capital Management, Ltd.	2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd.	2201 Interest of corporation controlled by you
S.i. Infrastructure Holdings Limited	2201 Interest of corporation controlled by you

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines